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University of San Francisco
CNL Online Program
Prospectus
Summary Brief
VAP Prevention in the CTICU
Pres Lorenzo BSN, RN, CCRN, CSC
Specific Aim: We aim to decrease the incidence of ventilator-associated pneumonia
(VAP) in the cardio-thoracic intensive care unit (CTICU) to zero within the next six
months (by August 31, 2015).
Background: The clinical microsystem is a busy 25-bed CTICU within a leading
academic medical center that is Magnet designated and nationally recognized as a center
for excellence in cardiovascular care. The patient acuity is typically high, and there has
been a 35% increase in the volume of cases within the past year. The patients are
admitted directly from surgery for post-operative care, the majority of whom require
mechanical ventilation. Despite diligent efforts by the staff to prevent VAP, such as rapid
extubation, mechanically ventilated patients (MVP) remain at risk for developing VAP.
Supportive Data: In 2014, four episodes of VAP were identified in the CTICU. The
Fishbone diagram (See Appendix A, Figure 1) delineates the potential causes of VAP,
which are categorized by staff, patients, policy and procedure, and documentation. The
Process Map (See Appendix B, Figure 1) illustrates the VAP prevention strategies
employed by the staff from the time the patient is admitted to the CTICU until
mechanical ventilation is discontinued.
Microsystem Status Relative to the project: The CTICU’s established record of zero
incidence of VAP, as well as its academic medical center status, provides incentive to
incorporate best practices. The SWOT analysis (See Appendix D, Figure 1) highlights the
resources available in the institution and the staff potentials, particularly in the
“strengths” and “opportunities” sections. The “weaknesses” and “threats” sections
identify the challenges that the staff must overcome in order to ensure the success of the
project. The recent episodes of VAP provided an impetus to participate in the CUSP 4
MVP-VAP or Comprehensive Unit-based Safety Program, which is aimed at improving
the care for mechanically ventilated patients. This quality improvement program is
federally funded through the Agency for Healthcare Research and Quality (AHRQ).
Search Strategies: The key words “VAP prevention” and “VAP prevention team” were
used to generate peer-reviewed articles that are relevant to the project, with dates ranging
from 2012 to 2014. The publications American Journal of Critical Care and Critical
Care Nurse as well as the Institute for Healthcare Improvement (IHI) website were
consulted for evidence-based information and guidelines for VAP prevention.
Databases Used: The search for evidence was performed using CINAHL and PubMed.
Summary of Evidence: The following articles strongly support the significance of
interdisciplinary rounding and adherence to the principles of evidence-based practice for
preventing VAP:
Goutier et al. (2014) suggest that the “Four E’s” model (Engage, Educate, Execute, and
Evaluate) promotes translation of guidelines or evidence into practice. Their study
validated a high compliance rate for evidence-based practice among institutions that
adopt this “Four E’s” model.

Mendez et al. (2013) emphasize the value of a specific rounding team, rather than the
primary medical team, that is tasked with addressing VAP prevention measures such as,
weaning from sedation. Their study revealed better compliance with “sedation vacation”
when managed by the ventilator rounding team, as opposed to the ICU rounding team.
Dosher et al. (2014) argue that a biweekly VAP prevention rounding to monitor staff
compliance with protocols reduced VAP rates.
The IHI, with its Ventilator Bundle (n.d.), proposes that interventions contained in the
guideline are more effective when implemented concurrently rather than separately.
Moreover, Sedwick et al. (2012) emphasize that strict adherence to bundled practices for
preventing VAP and interdisciplinary collaboration can significantly improve patient
outcomes.
Theoretical Direction: The ACE Star Model of Knowledge Transformation supports the
implementation of this project. This model follows a structured approach that includes
the following steps: (1) discovery of new knowledge; (2) summary of evidence; (3)
translation of the evidence for clinical practice; (4) integration of the recommended
change into practice; and (5) evaluation of the impact of the practice change (Schaffer,
Sandau, & Lee, 2012). These steps highlight the significance of incorporating the latest
evidence when designing an outcomes-driven clinical practice guideline. Integrating
change into practice remains the most challenging aspect of this evidence-based practice
model. In order to overcome this barrier, a group of champions are tasked to educate, role
model and evaluate staff, which will be explained further in the Methods section.
Stakeholders: The primary stakeholders of this project are the mechanically ventilated
patients in the CTICU and their families. Clinical key stakeholders include the CTICU
health care staff—physicians, nurses, respiratory therapists, and rehabilitation staff.
Business Case: According to the Agency for Healthcare Research and Quality (AHRQ),
VAP is the most common healthcare associated infection (HAI) in the ICU. It is costly
and contributes to an increase ICU length of stay. The average cost of treating each
episode of VAP is $40,000 to $57,000 (Sedwick, et al., 2012).
The cost associated with the project includes the Clinical Nurse Leader (CNL)
student/nurse champion’s salary for the 220 hours that were earmarked for educating staff
at the bedside and during staff meetings, conducting research and audits, preparing
reports, and attending meetings for an aggregate amount of $13,200. In addition, there is
also an incurred expense for purchasing 6 units of sub-glottic ETT suction devices, which
is valued at $4,200. In total, total project cost is $17,400. Conceivably, the savings that
will be generated by preventing merely one episode of VAP will compensate for the cost
to fund the project, thus yielding a minimum net benefit of $22,600, and a cost-benefit
ratio of 2.3 for every dollar spent (See Appendix F, Figure 1). Moreover, meeting the
goal of decreasing the VAP rate to zero each month within the next six months will save
the institution at least $240,000, which could offset direct care wages, such as payroll
costs.
The project’s non-monetary benefits include increased patient and family satisfaction,
and an enhanced reputation as a cutting-edge medical center. When clinical outcomes are
optimized, so too are the savings in healthcare cost. Therefore, the project yields a
positive return on investment.
Methods: Assessing the staff knowledge of VAP through online surveys and educating
them of its implications were significant aspects of the project’s implementation. During

the first six months, the focus was placed on reinforcing the Daily Care Processes for
VAP prevention as highlighted in the CUSP Wheel poster (See Appendix C, Figure 1),
which was displayed in the unit for educational purposes. The nursing champion
monitored staff compliance by conducting a daily audit of the Daily Care Processes while
simultaneously role modeling best practices to the staff. In addition, in-service
presentations were conducted to promote staff awareness of the impact of VAP and to
provide updates on the project’s progress.
Steps for Implementation: This 2-year multidisciplinary project commenced in January
2015. The specific activities in each phase of the project and the corresponding
evaluation tools are enumerated in the timeline chart (See Appendix E, Figure 1). In the
planning phase, the CUSP team organized and identified the potential causes of VAP in
the CTICU. In the initiation phase, the clinical staff’s knowledge and awareness of the
institution’s safety culture and VAP prevention protocols were evaluated through online
surveys. The execution phase focused on integrating evidence into practice through staff
education and role modeling of best practices. Also during this phase, the champions
monitored compliance with Daily Care Process measures and corrected the deficits that
were identified. In the later part of the execution phase, the team designed a progressive
mobilization plan for mechanically ventilated patients. The emphasis during the
monitoring phase is on staff compliance and consistency with adopting best practices.
Lastly, the effectiveness of the recommended CUSP VAP prevention measures was
appraised during the evaluation phase.
Evaluation: The effectiveness of the CUSP project will be validated by the reduction or
absence of VAP in the CTICU. The rate of staff adherence to VAP prevention measures
was monitored during the Daily Care Processes audits whose results are monitored and
analyzed each month for progress. These metrics are extremely valuable for measuring
the success of the project and for ensuring that the staff provides standardized and
evidenced-based care.
Results: The audit results revealed low compliance rate in the implementation of the
Daily Care Processes, particularly in the areas of SAT and SBT. In addition, insufficient
nursing and respiratory therapy collaboration and lack of standardized time for
performing SAT and SBT were identified. Lastly, the champions noted limited use of
sub-glottic ETT in the CTICU.
Outcomes: Since the project’s implementation, there have been no episodes of VAP
identified, which demonstrates the benefits of the CUSP guidelines. However, despite
this positive outcome, the gaps in clinical practice with regard to the implementation of
the Daily Care Processes, such as SAT and SBT, and the use of sub-glottic ETT need to
be addressed accordingly.
Recommendations: In order to sustain a zero VAP rate in the CTICU and correct gaps in
clinical practice, revision of policies to conform to CUSP guidelines, interdisciplinary
collaboration, and staff engagement are essential. A culture of inquiry must be promoted
to increase staff awareness of evidence-based practice. In addition, a CNL who possesses
an in-depth knowledge of the CTICU patient population, integrating evidence into
practice, and the role function of each member of the interdisciplinary team must be
employed to help facilitate this initiative. Lastly, hospital senior executives must be
solicited for their support of policy changes, and to appropriate funding for the necessary
resources (adequate staffing) and equipment (sub-glottic ETT and suction) to ensure the
continued success of this quality improvement project.

Appendix A
Fishbone Diagram

Fishbone Diagram

Staff/Personnel

Policy & Procedure

Limited amount of staff for actual and
anticipated rise in volume of patients

Sub-glottic ETT not routinely used in CTICU

Communication gaps between providers

Adherence to oral care policy

Nursing staff turnover

Compliance with sedation vacation
Standard time for performing SAT and SBT

Rotating medical staff (residents)

Multiple areas to document patient progress

High acuity and co-morbidities
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Figure 1. Fishbone Diagram. This figure delineates the potential causes of VAP in the CTICU
into different categories.

Appendix B
Process Map for VAP Prevention in the CTICU

Figure 1. Process Map. This algorithm demonstrates the appropriate steps of implementing the
rapid extubation protocol in the CTICU, which is a VAP prevention measure.

Appendix C
CUSP Wheel

Figure 1. CUSP Wheel. The highlighted section of the CUSP Wheel poster illustrates the Daily
Care Processes for VAP prevention, which was the focus of the project.

Appendix D
SWOT Analysis of the VAP Prevention Project

•
•

•
•
•
•

•
•
•

Strengths
Staff commitment for optimizing
clinical outcomes
Availability of clinical resources and
experts given its academic medical
center setting
Maximum RN/patient ratio in the ICU
of 1:2
Rapid extubation protocol for cardiac
surgery patients
Daily multidisciplinary rounds
Opportunities
To participate in a multi-center patient
safety and quality improvement
project
To incorporate best practices based on
current evidence
To promote patient-family centered
care
To foster teamwork among CTICU
staff

•
•
•
•
•

•

•
•

Weaknesses
Recent high nursing staff turnover
Inadequate staff education about the
implications of the project
Inconsistencies with the use of subglottic ETT
Low adherence to established
protocols by some staff
Constant change in medical staff
coverage
Threats
High patient acuity and clinical
instability that my hinder rapid
extubation and other VAP prevention
measures
Multiple competing projects
Projects are perceived as additional
work for frontline clinicians

Figure 1. SWOT Analysis. This figure highlights the significance and challenges of
implementing the CUSP 4 MVP-VAP prevention project.

Appendix E
Activities Timeline

Figure 1. Activities Timeline. This figure chronicles the specific activities in each phase of the
VAP prevention project during the first six months of implementation.

Appendix F
Cost Benefit Analysis and Cost Benefit Ratio

Item

Cost

Net Benefit

Each episode of VAP

$40,000

Nurse champion salary (220 hours)

$13,200

$26,800

Suction equipment

$4,200

$35,800

Total project cost

$17,400

$22,600

Cost benefit ratio

2.3 for every dollar spent

Figure 1. Cost Benefit Analysis and Cost Benefit Ratio. Bold written items include the cost to
treat each episode of VAP, total project cost, net benefit, and cost-benefit ratio.
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